Zhenfei Bi
Impact in
-
- interferon and immune responses
Papers in
-
- Inflammasome and immune disorders 3
-
- Immune cells in cancer 4
- interferon and immune responses 3
- Immune Response and Inflammation 3
- Co-authors
- Xiawei Wei (13 shared papers)Yuquan Wei (8 shared papers)Yanlin Song (4 shared papers)H. J. Yang (10 shared papers)Yu Liu (2 shared papers)Weiqi Hong (7 shared papers)Xuelei Ma (2 shared papers)Zhe Zhang (3 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (3 papers)Theranostics (2 papers)European Journal of Medicinal Chemistry (1 paper)Cellular and Molecular Immunology (1 paper)RSC Advances (1 paper)
- Partner nations
- China
In The Last Decade
Zhenfei Bi
18 papers receiving 503 citations
Peers
Comparison fields: 5 of 94
- Immunology 111
- Cancer Research 50
- Molecular Biology 225
- Genetics 30
- Infectious Diseases 47
Countries citing papers authored by Zhenfei Bi
This map shows the geographic impact of Zhenfei Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenfei Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenfei Bi more than expected).
Fields of papers citing papers by Zhenfei Bi
This network shows the impact of papers produced by Zhenfei Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenfei Bi. The network helps show where Zhenfei Bi may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenfei Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 119 | |
| 2 | 2022 | 55 | |
| 3 | 2020 | 53 | |
| 4 | 2020 | 43 | |
| 5 | 2021 | 37 | |
| 6 | 2023 | 35 | |
| 7 | 2021 | 26 | |
| 8 | 2017 | 25 | |
| 9 | 2023 | 24 | |
| 10 | 2021 | 24 | |
| 11 | 2022 | 22 | |
| 12 | 2016 | 18 | |
| 13 | 2022 | 10 | |
| 14 | 2021 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2024 | 4 | |
| 17 | 2025 | 2 | |
| 18 | 2022 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Zhenfei Bi
Zhenfei Bi is a scholar working on Molecular Biology, Immunology, Infectious Diseases, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 20 papers that have together received 509 indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), interferon and immune responses (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Immune Response and Inflammation (3 papers), Inflammasome and immune disorders (3 papers), Long-Term Effects of COVID-19 (2 papers), Nanoplatforms for cancer theranostics (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Immunology (111 citations), Cancer Research (50 citations), Molecular Biology (225 citations), Genetics (30 citations) and Infectious Diseases (47 citations). Zhenfei Bi has collaborated with scholars based in China. Frequent co-authors include Xiawei Wei, Yuquan Wei, Yanlin Song, H. J. Yang, Yu Liu, Weiqi Hong, Xuelei Ma, Zhe Zhang, Fei Mo and Lu Sun. Their work appears in journals such as Signal Transduction and Targeted Therapy, Theranostics, European Journal of Medicinal Chemistry, Cellular and Molecular Immunology and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.